Technology | January 07, 2013

Elekta receives 510(k) clearance for MOSAIQ Evaluate, a toolset that integrates treatment planning features into MOSAIQ OIS

MOSAIQ Oncology Information System MOSAIQ Evaluate Treatment Planning

January 7, 2013 — As part of a process to completely integrate the patient's electronic medical record (EMR) with treatment planning activities, Elekta has introduced MOSAIQ Evaluate, a toolset that unites plan and dose review capabilities in a single software framework, MOSAIQ Oncology Information System (OIS). Uniting MOSAIQ and powerful treatment planning review capabilities streamlines planning activities inside the patient chart, reducing patient wait times and delays and improving efficiency and productivity in the department. Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MOSAIQ Evaluate.

"The development of MOSAIQ Evaluate establishes a new standard of oncology treatment planning management in a single software environment. Our belief is that clinical decision-making is improved when the radiotherapy team can access and review treatment and patient data from one source, MOSAIQ," says Todd Powell, executive vice president, Elekta Software. "It's the first step in a process in which we will steadily integrate advanced toolsets inside MOSAIQ, ultimately creating an advanced, comprehensive treatment planning solution inside the EMR."

With MOSAIQ Evaluate, the entire radiation oncology team can access and review treatment plans and patient data from the patient's chart, streamlining the radiotherapy workflow. It enables plan review from virtually any treatment planning system and for any treatment modality, in addition to comparison of multiple plans.

To support the multidisciplinary team, MOSAIQ Evaluate offers specific benefits for the radiation oncologist, the physicist and the dosimetrist. Radiation oncologists and physicists will now be able to review plans at their MOSAIQ workstation and view a "to-do" list of plans needing review. MOSAIQ Evaluate also enables the physicist to identify approved plan information side-by-side with all treatment fields, approve treatment fields directly from the Plan Worklist, and view imported DRR's alongside the treatment plan. With MOSAIQ Evaluate, dosimetrists will be able to use the Plan Worklist to identify approved plans, triggering the next step in the workflow.

For more information: www.elekta.com


Related Content

News | Artificial Intelligence

July 11, 2024 — Artificial Intelligence (AI) tools can play a key role in medical imaging if radiologists trust in their ...

Time July 11, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | Oncology Information Management Systems (OIMS)

May 21, 2024 — RaySearch Laboratories AB announced that the oncology information system RayCare* 2024A has been ...

Time May 21, 2024
arrow
News | Radiation Therapy

May 1, 2024 — Sun Nuclear, a Mirion Medical company, today announced the upcoming version 5.0 release of its SunCHECK ...

Time May 01, 2024
arrow
News | Radiation Therapy

April 18, 2024 — Accuray Incorporated announced that as part of its commitment to advancing patient care the company has ...

Time April 18, 2024
arrow
News | Radiation Oncology

February 12, 2024 — Radformation, a global pioneer in radiation oncology software solutions, is pleased to announce its ...

Time February 12, 2024
arrow
News | Artificial Intelligence

December 5, 2023 — Pixyl has announced FDA 510(k) clearance for Pixyl.Neuro, the next-generation AI software for brain ...

Time December 05, 2023
arrow
News | Proton Therapy

July 5, 2023 — RaySearch Laboratories AB announced a strategic collaboration agreement with B dot Medical Inc. aimed at ...

Time July 05, 2023
arrow
News | Radiation Oncology

May 31, 2023 — Elekta announced the launch of the first phase of Elekta ONE*, its most comprehensive and advanced ...

Time May 31, 2023
arrow
Subscribe Now